Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The authors assessed the use of herbal medicine by Middle Eastern patients with cancer, as reported by their oncology health care professionals (HCPs). Herbal products identified by the study HCPs were evaluated for potential negative effects. METHODS: Oncology HCPs from 16 Middle Eastern countries received a 17‐item questionnaire asking them to list 5 herbal products in use by their patients with cancer. A literature search (PubMed, Micromedex, AltMedDex, and the Natural Medicine Comprehensive Database) was conducted to identify safety‐related concerns associated with the products listed. RESULTS: A total of 339 HCPs completed the study questionnaire (response rate of 80.3%), identifying 44 herbal and 3 nonherbal nutritional supplements. Safety‐related concerns were associated with 29 products, including herb‐drug interactions with altered pharmacodynamics (15 herbs), direct toxic effects (18 herbs), and increased in vitro response of cancer cells to chemotherapy (7 herbs). CONCLUSIONS: Herbal medicine use, which is prevalent in Middle Eastern countries, has several potentially negative effects that include direct toxic effects, negative interactions with anticancer drugs, and increased chemosensitivity of cancer cells, requiring a reduction in dosedensity. Oncology HCPs working in countries in which herbal medicine use is prevalent need to better understand the implications of this practice. The presence of integrative physicians with training in complementary and traditional medicine can help patients and their HCPs reach an informed decision regarding the safety and effective use of these products. Cancer 2016;122:598–610. © 2015 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer
Banerjee, S., Kaseb, A. O., Wang, Z., Kong, D., Mohammad, M., Padhye, S., Sarkar, F. H., & Mohammad, R. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4235 · Cited by 244 · cited 1×
“9%) (Table 3).(37-93) These were grouped according to 3 predominant themes: 1) potentially harmful herb-drug interactions with a reduction in bioavailability (and thus efficacy) of anticancer agents, or increased drug levels with increased toxicity (15 herbs; 34.”
BackgroundRetractedEncyclopedia of common natural ingredients used in food, drugs and cosmetics
(1982) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(82)90080-0 · Cited by 1,025
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
Dürr, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.112240 · Cited by 584 · cited 3×
“7) 6 Camel milk Sudan 2 1 (50) 1 Syria 1 1 (100) 1 Tunisia 3 1 (33.”
BackgroundHerbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom, A., Cox, M. C., Acharya, M. R., & Figg, W. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.182 · Cited by 473 · cited 1×
“As a result, there are those in the medical profession who have issued an across-the-board recommendation to avoid the use of all herbal products during active anticancer treatment.(24) Although this may be prudent, it is a somewhat unrealistic solution for oncology HCPs working in communities in which herbal medicine…”
BackgroundThe effect of garlic supplements on the pharmacokinetics of saquinavir
Piscitelli, S. C., Burstein, A. H., Welden, N., Gallicano, K. D., & Falloon, J. (2002) · Clinical Infectious Diseases · doi:10.1086/324351 · Cited by 431 · cited 4×
“These were mediated primarily through the cytochrome P450 enzymes, primarily induction of CYP3A4.(37,38) CYP induction can cause a reduction in bioavailability and subsequently the effectiveness of anticancer agents,(39-41) whereas enzyme inhibition can increase the risk of toxicity, such as that observed with etoposi…”
BackgroundInfluentialDisclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies
Robinson, A., & McGrail, M. R. (2004) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2004.09.006 · Cited by 409 · cited 1×
“This allowed us to avoid several patient-based biases, such as a reporting bias resulting from nondisclosure of CTM use to researchers who patients may have believed had a negative attitude regarding nonconventional medical approaches.(101) For this purpose, we asked oncology HCPs to provide a list of herbal products…”
MethodSt John's wort (Hypericum perforatum): drug interactions and clinical outcomes
Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B., & Arlett, P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01683.x · Cited by 380 · cited 4×
“These were mediated primarily through the cytochrome P450 enzymes, primarily induction of CYP3A4.(37,38) CYP induction can cause a reduction in bioavailability and subsequently the effectiveness of anticancer agents,(39-41) whereas enzyme inhibition can increase the risk of toxicity, such as that observed with etoposi…”
BackgroundInfluentialInhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil
Petroni, A., Blasevich, M., Salami, M., Papini, N., Montedoro, G. F., & Galli, C. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00043-7 · Cited by 363 · cited 1×
“9%) (Table 3).(37-93) These were grouped according to 3 predominant themes: 1) potentially harmful herb-drug interactions with a reduction in bioavailability (and thus efficacy) of anticancer agents, or increased drug levels with increased toxicity (15 herbs; 34.”
BackgroundPotential interactions between alternative therapies and warfarin
Heck, A. M., DeWitt, B. A., & Lukes, A. L. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.13.1221 · Cited by 355 · cited 1×
“9%) (Table 3).(37-93) These were grouped according to 3 predominant themes: 1) potentially harmful herb-drug interactions with a reduction in bioavailability (and thus efficacy) of anticancer agents, or increased drug levels with increased toxicity (15 herbs; 34.”
Background
Cited by
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 231
Metadata
- Authors
- Ben‐Arye, E., Samuels, N., Goldstein, L. H., Mutafoglu, K., Omran, S., Schiff, E., Charalambous, H., Dweikat, T., Ghrayeb, I., Bar‐Sela, G., Turker, I., Hassan, A., Hassan, E., Saad, B., Nimri, O., Kebudi, R., & Silbermann, M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2015-11-24
- Volume
- 122
- Issue
- 4
- Pages
- 598-610
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2178767900
- Cited by
- 158
- References
- 79
- FWCI
- 17.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. https://app.cochat.ai/papers/10.1002/cncr.29796
- The paper
- Ben‐Arye, E., Samuels, N., Goldstein, L. H., Mutafoglu, K., Omran, S., Schiff, E., Charalambous, H., Dweikat, T., Ghrayeb, I., Bar‐Sela, G., Turker, I., Hassan, A., Hassan, E., Saad, B., Nimri, O., Kebudi, R., & Silbermann, M. (2016). Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. Cancer. https://doi.org/10.1002/cncr.29796
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.